MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway
Keyword(s):
2018 ◽
Vol 234
(6)
◽
pp. 9077-9092
◽
Keyword(s):
2009 ◽
Vol 21
(4)
◽
pp. 247-254
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2010 ◽
Vol 15
(10)
◽
pp. 448
◽
Keyword(s):
2014 ◽
Vol 21
(2)
◽
pp. 67-72
◽
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 82
(6)
◽
pp. 1049-1059
◽